Cytokine gene polymorphisms and severity of CF lung disease
- PMID: 24853301
- DOI: 10.1016/j.jcf.2014.04.007
Cytokine gene polymorphisms and severity of CF lung disease
Abstract
Background: The search for modifier genes to explain inconsistencies in cystic fibrosis (CF) genotype-phenotype relationships has yielded mixed results. In a previous cross-sectional study from our centre the clinical effect (as described by FEV1, BMI z-score, admitted days and NIH score) of single nucleotide polymorphisms (SNPs) of four cytokine genes (IL-8, TNF-α, IL-1β and IL-10) was examined in 158 children with CF. No association between cytokine genotype and any biological outcome measure was found. In this present study a cross-sectional and longitudinal examination of this relationship was undertaken to test the hypothesis that pro-inflammatory SNPs would affect longitudinal changes in CF lung disease.
Methods: Using the cohort examined in our earlier study we performed both longitudinal and cross-sectional data analyses examining the relationship between SNPs (TNF-α, IL-8, IL-10 and IL-1β) and clinical outcome measurements. In the first part of this current study, lung function data (annual decline of FEV1 percent predicted) was compared with the cytokine genotype over a 13 year period. In the second part of this current study multiple regression was used to assess associations between clinical outcomes (best FEV1 percent predicted and BMI at the age of 10 years) and alleles of cytokine genes, adjusting for gender, CF genotype and lung infection status.
Results: A total of 152 patients with CF were analysed in the longitudinal study and data from 130 patients at the age of 10 years were analysed in the cross-sectional study. There was evidence for an association between pro-inflammatory SNPs of the IL-8, IL-10 and IL-1β genes and more severe lung disease. Multiple regression of the longitudinal data with a total of 10,956 lung function measurements showed an additional annual decline of the percentage predicted FEV1 of -1.15 (IL-8, p<0.001), -0.24 (IL-10, p=0.049) and -0.41 (IL-1β, p<0.001) for patients with any of the pro-inflammatory alleles. None of the cross-sectional data showed a significant association between the cytokine genotypes and the clinical outcomes.
Conclusion: Pro-inflammatory alleles of three cytokine genotypes, IL-8, IL-10 and IL-1β, appear to be associated with slightly more severe lung disease in patients with CF over a 13 year period. Further studies are required to exclude influence of confounders on the severity of lung disease.
Keywords: Cystic fibrosis; Cytokine genotype; Modifier genes; Single nucleotide polymorphism.
Copyright © 2014 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Genetic variations in toll-like receptor pathway and lung function decline in Cystic fibrosis patients.Hum Immunol. 2013 Dec;74(12):1649-55. doi: 10.1016/j.humimm.2013.08.282. Epub 2013 Aug 29. Hum Immunol. 2013. PMID: 23994582
-
Cytokine gene polymorphisms in hemodialysis patients: association with comorbidity, functionality, and serum albumin.Kidney Int. 2004 Apr;65(4):1449-60. doi: 10.1111/j.1523-1755.2004.00531.x. Kidney Int. 2004. PMID: 15086488
-
Growth in prepubertal children with cystic fibrosis, homozygous for the Delta F508 mutation.J Cyst Fibros. 2003 Jun;2(2):76-83. doi: 10.1016/S1569-1993(03)00023-7. J Cyst Fibros. 2003. PMID: 15463854
-
Meta-analysis of association between cytokine gene polymorphisms and Behcet's disease risk.Int J Rheum Dis. 2013 Dec;16(6):616-24. doi: 10.1111/1756-185X.12221. Epub 2013 Nov 25. Int J Rheum Dis. 2013. PMID: 24267724 Review.
-
Impaired glucose tolerance, body mass index and respiratory function in patients with cystic fibrosis: A systematic review.Clin Respir J. 2019 Jun;13(6):341-354. doi: 10.1111/crj.13019. Epub 2019 Apr 16. Clin Respir J. 2019. PMID: 30919537
Cited by
-
Lung Inflammatory Genes in Cystic Fibrosis and Their Relevance to Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapies.Genes (Basel). 2023 Oct 20;14(10):1966. doi: 10.3390/genes14101966. Genes (Basel). 2023. PMID: 37895314 Free PMC article. Review.
-
Impact of Gene Modifiers on Cystic Fibrosis Phenotypic Profiles: A Systematic Review.Hum Mutat. 2024 Oct 16;2024:6165547. doi: 10.1155/2024/6165547. eCollection 2024. Hum Mutat. 2024. PMID: 40225935 Free PMC article.
-
The Contribution of the Airway Epithelial Cell to Host Defense.Mediators Inflamm. 2015;2015:463016. doi: 10.1155/2015/463016. Epub 2015 Jun 21. Mediators Inflamm. 2015. PMID: 26185361 Free PMC article. Review.
-
IL1B gene variants, but not TNF, CXCL8, IL6 and IL10, modify the course of cystic fibrosis in Polish patients.F1000Res. 2022 Nov 22;11:379. doi: 10.12688/f1000research.110472.3. eCollection 2022. F1000Res. 2022. PMID: 39185143 Free PMC article.
-
Neutrophil extracellular traps and interleukin-1β in cystic fibrosis lung disease.Front Immunol. 2025 Jul 28;16:1595994. doi: 10.3389/fimmu.2025.1595994. eCollection 2025. Front Immunol. 2025. PMID: 40791588 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical